A multicentrer randomised open label parallel group study to assess the effects of Philips Respironic's Adaptive Servo Ventilation device (ASV) on mortality and cardiovascular (CV) morbidity in patients with chronic heart failure (HF) who also suffer from sleep apnea

Hdl Handle:
http://hdl.handle.net/10147/241765
Title:
A multicentrer randomised open label parallel group study to assess the effects of Philips Respironic's Adaptive Servo Ventilation device (ASV) on mortality and cardiovascular (CV) morbidity in patients with chronic heart failure (HF) who also suffer from sleep apnea
Issue Date:
7-Sep-2012
URI:
http://hdl.handle.net/10147/241765
Ethical Approval:
Yes
Start Date:
2010-10-06

Full metadata record

DC FieldValue Language
dc.date.accessioned2012-09-07T10:25:25Z-
dc.date.available2012-09-07T10:25:25Z-
dc.date.issued2012-09-07-
dc.identifier.urihttp://hdl.handle.net/10147/241765-
dc.titleA multicentrer randomised open label parallel group study to assess the effects of Philips Respironic's Adaptive Servo Ventilation device (ASV) on mortality and cardiovascular (CV) morbidity in patients with chronic heart failure (HF) who also suffer from sleep apneaen_GB
dc.type.qualificationlevelN/Aen
cr.approval.ethicalYesen
cr.date.start2010-10-06-
dc.description.provinceLeinsteren
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.